WAC 246-225-120
Therapeutic X-ray installations less
than 1 MeV. (1) Equipment requirements.
(a) Leakage radiation. When the tube is operated at its
leakage technique factors, the leakage radiation shall not
exceed the value specified at the distance specified for the
classification of that X-ray system:
(i) Contact therapy systems. Leakage radiation shall not
exceed 100 milliroentgens per hour at five centimeters from
the surface of the tube housing assembly;
(ii) Zero to one hundred fifty kVp systems. Systems
shall have a leakage radiation which does not exceed one
roentgen in one hour at one meter from the source;
(iii) One hundred fifty-one to nine hundred ninety-nine
kVp systems. The leakage radiation shall not exceed one
roentgen in one hour at one meter from the source except
systems that operate in excess of 500 kVp may have a leakage
radiation at one meter from the source equivalent to the
exposure within one hour of the useful beam at one meter from
the source multiplied by a factor of 0.001.
(b) Permanent beam limiting devices. Permanent fixed
diaphragms or cones used for limiting the useful beam shall
provide the same or higher degree of protection as that
required by the tube housing assembly.
(c) Removable and adjustable beam limiting devices.
(i) Removable beam limiting devices shall, for the
portion of the useful beam to be blocked by these devices,
transmit not more than one percent of the original X-ray beam
at the maximum kilovoltage and maximum treatment filter;
(ii) Adjustable beam limiting devices installed after the
effective date of this section shall meet the requirements of
(c)(i) of this subsection;
(iii) Adjustable beam limiting devices installed before
the effective date of this section shall, for the portion of
the X-ray beam to be blocked by these devices, transmit not
more than five percent of the original X-ray beam at the
maximum kilovoltage and maximum treatment filter.
(d) Filter and wedge systems. Filter systems shall meet
the following requirements:
(i) Filters cannot be accidently displaced from the
useful beam at any possible tube orientation;
(ii) Each filter is marked as to its material of
construction and its thickness or wedge angle for wedge
filters;
(iii) It shall be possible for the operator to determine
the presence or absence of each filter in the useful beam when
the operator is at the control panel, either by display at the
control panel or by direct observation; and
(iv) The filter insertion slot opening shall be covered
with an attenuator equivalent to four-pound lead under
operating conditions.
(e) Tube immobilization. The tube housing assembly shall
be capable of being immobilized during stationary treatments.
(f) Focal spot marking. The tube housing assembly shall
be so marked that it is possible to determine the location of
the focal spot to within five millimeters, and such marking
shall be readily accessible for use during calibration
procedures.
(g) Timer.
(i) A timer shall be provided which has a display at the
treatment control panel. The timer shall be graduated in
minutes and fractions of minutes. The timer shall have a
preset time selector and a means of determining elapsed time;
(ii) The timer shall be a cumulative timer which
activates with radiation and retains its reading after
irradiation is interrupted or terminated;
(iii) The timer shall terminate irradiation when a
preselected time has elapsed;
(iv) The timer shall permit accurate presetting and
determination of exposure times as short as 1 second;
(v) The timer shall terminate irradiation when set to
zero;
(vi) The timer shall not activate until the shutter is
opened, when patient irradiation is controlled by a shutter
mechanism.
(h) Control panel functions. The control panel, in
addition to the displays required in other provisions of this
chapter, shall have:
(i) An indication of whether X rays are being produced;
(ii) Means for indicating kV and X-ray tube current;
(iii) The means for terminating an exposure at any time;
(iv) A locking device which will prevent unauthorized use
of the X-ray system; and
(v) For X-ray equipment manufactured after the effective
date of this section, a positive display of specific filter(s)
in the beam.
(i) Source-to-patient distance. There shall be means of
determining the source-to-patient distance to within five
millimeters.
(j) Shutters. Unless it is possible to bring the X-ray
output to the prescribed exposure parameters within five
seconds, the entire useful beam shall be automatically
attenuated by a shutter having a lead equivalency not less
than that of the tube housing assembly. In addition:
(i) After the unit is at operating parameters, the
shutter shall be controlled electrically by the operator from
the control panel;
(ii) An indication of shutter position shall appear at
the control panel.
(k) Low filtration X-ray tubes. Each X-ray system
equipped with a beryllium or other low-filtration window shall
be clearly labeled as such upon the tube housing assembly and
at the control panel;
(l) Alignment. When the therapy X-ray system is equipped
with a light field indicating the X-ray field, the
misalignment of one field edge to the other shall not exceed
one percent of any source-to-treatment distance.
(2) Facility design requirements for systems capable of
operating above 50 kVp.
In addition to shielding adequate to meet requirements of
chapters 246-235 and 246-221 WAC and the shielding plan review
provisions of WAC 246-225-030, the treatment room shall meet
the following design requirements:
(a) Warning lights. Treatment rooms to which access is
possible through more than one entrance shall be provided with
warning lights, in a readily observable position near the
outside of all access doors, which will indicate when the
useful beam is "on." Or, as an alternative, entrances other
than the main one shall be equipped with interior locks,
activated for the period of exposure, and the main entrance
shall be under control of the operator.
(b) Voice communication. Provision shall be made for
two-way aural communication between the patient and the
operator at the control panel; however, where excessive noise
levels make aural communication impractical, other methods of
communication shall be used.
(c) Viewing systems. Windows, mirrors, closed-circuit
television, or an equivalent system shall be provided to
permit continuous observation of the patient during
irradiation and shall be so located that the operator can
observe the patient from the control panel. When the primary
viewing system is by electronic means (e.g., television), an
alternate viewing system shall be available for use in the
event of electronic failure or treatment must be discontinued
until repair is made. If treatment is to be discontinued,
this policy shall be included in the written safety
procedures. A copy of the safety procedures shall be provided
to the operator.
(d) Additional requirements. Treatment rooms which
contain an X-ray system capable of operating above 150 kVp
shall meet the following additional requirements:
(i) All necessary shielding, except for any beam
interceptor, shall be provided by fixed barriers;
(ii) The control panel shall be outside the treatment
room;
(iii) All doors of the treatment room shall be
electronically connected to the control panel such that X-ray
production cannot occur unless all doors are closed;
(iv) When the doors referred to in (d)(iii) of this
subsection are opened while the X-ray tube is activated:
(A) X-ray production shall terminate within one second;
or
(B) The radiation at a distance of one meter from the
source shall be reduced to less than 100 milliroentgens per
hour within one second.
(v) After the radiation output of the X-ray tube has been
affected by the opening of any door referred to in (d)(iii) of
this subsection, it shall be possible to restore the X-ray
system to full operation only upon:
(A) Closing the door; and subsequently
(B) Reinitiating the exposure at the control panel.
(e) Calibrations.
(i) The calibration of an X-ray system shall be performed
at intervals not to exceed one year and after any change or
replacement of components which could cause a change in the
radiation output.
(ii) The calibration of the radiation output of the X-ray
system shall be performed by a qualified expert who is
physically present at the facility during such calibration.
(iii) Calibration of the radiation output of an X-ray
system shall be performed with a calibrated instrument. The
calibration of such instrument shall be traceable to a
national standard. The instrument shall have been calibrated
within the preceding two years.
(iv) The calibrations made pursuant to (e)(i) of this
subsection shall be such that the dose at a reference point in
soft tissue can be calculated to within ± five percent.
(v) The calibration of the X-ray system shall include,
but not be limited to, the following determinations:
(A) The exposure rates for each combination of field
size, technique factors, filter, and treatment distance used;
(B) The degree of alignment between the radiation field
and the field indicated by the localizing device if such
device is present; and
(C) An evaluation of the uniformity of the radiation
field symmetry for the field sizes used and any dependence
upon tube housing assembly orientation.
(vi) Records of calibration performed pursuant to (e) of
this subsection shall be maintained by the registrant for two
years after completion of the calibration.
(vii) A copy of the most recent X-ray system calibration
shall be available for use by the operator at the control
panel.
(f) Operating procedures.
(i) When a patient must be held in position for radiation
therapy, mechanical supporting or restraining devices shall be
used;
(ii) The tube housing assembly shall not be held by an
individual during exposures;
(iii) No individual other than the patient shall be in
the treatment room unless such individual is protected by a
barrier sufficient to meet the requirements of chapter 246-221
WAC. No individual other than the patient shall be in the
treatment room during exposures when the kVp exceeds 150;
(iv) The X-ray system shall not be used in the
administration of radiation therapy unless the requirements of
(e) of this subsection have been met.
[Statutory Authority: RCW 70.98.050 and 70.98.080. 91-15-083
(Order 183), § 246-225-120, filed 7/23/91, effective 8/23/91. Statutory Authority: RCW 43.70.040. 91-02-049 (Order 121),
recodified as § 246-225-120, filed 12/27/90, effective
1/31/91. Statutory Authority: RCW 70.98.080. 87-01-031
(Order 2450), § 402-28-091, filed 12/11/86; 83-19-050 (Order
2026), § 402-28-091, filed 9/16/83. Statutory Authority: RCW 70.98.050. 81-01-011 (Order 1570), § 402-28-091, filed
12/8/80.]